These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5122727)

  • 1. [Analysis of various chemico-pharmaceutical sulfur preparations by in oxygen burning].
    Kofman MD; Arzamastsev OP
    Farm Zh; 1971; 26(3):52-6. PubMed ID: 5122727
    [No Abstract]   [Full Text] [Related]  

  • 2. Ratio spectra derivative spectrophotometry for the determination of furosemide and spironolactone in a capsule formulation.
    Millership JS; Parker C; Donnelly D
    Farmaco; 2005 Apr; 60(4):333-8. PubMed ID: 15848209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.
    Ram VR; Dave PN; Joshi HS
    J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The iodine complex of some drugs containing organically bound bivalent sulfur].
    Zöllner G; Vastagh G
    Acta Pharm Hung; 1970 Jan; 40(1):29-37. PubMed ID: 4189995
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in analytical determination of furosemide.
    Espinosa Bosch M; Ruiz Sánchez AJ; Sánchez Rojas F; Bosch Ojeda C
    J Pharm Biomed Anal; 2008 Nov; 48(3):519-32. PubMed ID: 18701232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and simple radioactive method for the determination of disulfiram and its metabolites from a single sample of biological fluid or tissue.
    Faiman MD; Dodd DE; Nolan RJ; Artman L; Hanzlik RE
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):481-96. PubMed ID: 197575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved high-performance liquid chromatography assay for spironolactone analysis.
    Alexander KS; Vangala SS; Dollimore D
    Drug Dev Ind Pharm; 1998 Feb; 24(2):101-7. PubMed ID: 15605439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the bioequivalence of 2 oral preparations containing spironolactone and furosemide.
    Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):231-8. PubMed ID: 9587051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrochemical methods in pharmaceutical analysis. IV. Application of constant intensity coulometry to the automatic assay of organic sulfur compounds].
    Sement E; Rousselet F; Girard ML; Chemla M
    Ann Pharm Fr; 1972 Oct; 30(10):691-700. PubMed ID: 4656587
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of active principles in pharmaceutical dosage forms by high pressure liquid chromatography - spironolactone and hydrochlorothiazide].
    La Rotonda MI; Cozzolino S; Schettino O
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1399-404. PubMed ID: 7448034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The refractory susceptibility in determination of sulfur in organic drugs using the Schoniger method].
    Listov SA; Arsamastsev AP; Gamanina GJ
    Pharmazie; 1988 Oct; 43(10):686-9. PubMed ID: 3212013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorimetric determination of disulfiram in tablets: collaborative study.
    Wojtowicz EJ; Hanus JP; Johnson RH; Lazar A; Olsen RE; Newton JM; Petzinger G; Ristich R; Robinette ML
    J Assoc Off Anal Chem; 1981 May; 64(3):554-6. PubMed ID: 7240062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

  • 14. pH-induced difference spectrophotometric assay of acetazolamide, hydrochlorothiazide, and furosemide.
    Abdine H; Elsayed MA; Elsayed YM
    J Assoc Off Anal Chem; 1978 May; 61(3):695-701. PubMed ID: 25877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram determination by proton magnetic resonance spectroscopy and by colorimetry.
    Sheinin EB; Benson WR; Smith MM
    J Assoc Off Anal Chem; 1973 Jan; 56(1):124-7. PubMed ID: 4781029
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of composition of mixtures of minigranules on the liberation of furosemide].
    Meddeb F; Brossard C; Wouessidjewe D; Devissaguet JP
    Pharm Acta Helv; 1989; 64(11):307-11. PubMed ID: 2608689
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples.
    Sora DI; Udrescu S; Albu F; David V; Medvedovici A
    J Pharm Biomed Anal; 2010 Sep; 52(5):734-40. PubMed ID: 20307949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of low concentrations of disulfiram by cathode ray polarography.
    Porter GS; Williams A
    J Pharm Pharmacol; 1972 Dec; 24():Suppl:144P-145. PubMed ID: 4144868
    [No Abstract]   [Full Text] [Related]  

  • 19. Adsorption of organic compounds by commercial filter papers and its implication on quantitative--qualitative chemical analysis.
    Chiou WL; Smith LD
    J Pharm Sci; 1970 Jun; 59(6):843-7. PubMed ID: 5423091
    [No Abstract]   [Full Text] [Related]  

  • 20. Furosemide and spironolactone reduce transmigration of leukocytes through endothelial cell monolayers.
    Hofbauer R; Frass M; Pasching E; Gmeiner B; Kaye AD; Kapiotis S
    J Toxicol Environ Health A; 2002 May; 65(9):685-93. PubMed ID: 11996409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.